Filtros de búsqueda

Lista de obras de

A Safety Evaluation of Empagliflozin for the Treatment of Type 2 Diabetes

artículo científico publicado en 2015

A Test in Context: Hemoglobin A1c and Cardiovascular Disease

artículo científico publicado en 2016

A forty-year follow-up of the Dallas Bed Rest and Training study: the effect of age on the cardiovascular response to exercise in men.

artículo científico publicado en 2009

A risk score for predicting coronary artery disease in women with angina pectoris and abnormal stress test finding

scholarly article by Monica Y Lo et al published 28 December 2012 in American Journal of Cardiology

Accuracy of estimating resting oxygen uptake and implications for hemodynamic assessment.

artículo científico publicado en 2011

Adiponectin and cardiovascular risk profile in patients with type 2 diabetes mellitus: parameters associated with adiponectin complex distribution ⬇️

artículo científico publicado el 9 de mayo de 2011

Advances and continued controversy in coronary revascularization of patients with diabetes mellitus

artículo científico publicado en 2003

Aerobic Fitness and Adherence to Guideline-Recommended Minimum Physical Activity Among Ambulatory Patients With Type 2 Diabetes Mellitus

artículo científico publicado en 2019

African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study

artículo científico publicado en 2004

Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks

scientific article published on 01 May 2019

Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay.

artículo científico publicado en 2014

Antihyperglycemic therapies and cardiovascular outcomes in patients with type 2 diabetes mellitus: State of the art and future directions

scientific article published on 07 January 2020

Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes

scientific article published on 30 April 2019

Application of the screening for Heart Attack Prevention and Education Task Force recommendations to an urban population: observations from the Dallas Heart Study

artículo científico publicado en 2008

Aspirin, clopidogrel, or both for secondary prevention of coronary disease

artículo científico publicado en 2003

Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).

artículo científico publicado en 2017

Assessing use of patient-focused pharmacotherapy in glycemic management through the Diabetes Collaborative Registry (DCR)

artículo científico publicado en 2018

Assessment of cardiac structure and function in patients without and with peripheral oedema during rosiglitazone treatment

artículo científico publicado en 2011

Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial

artículo científico publicado en 2018

Association Between HbA1c Levels and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Cardiovascular Disease: A Secondary Analysis of the TECOS Randomized Clinical Trial

artículo científico publicado en 2020

Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial

artículo científico

Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis

artículo científico publicado en 2004

Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study.

artículo científico publicado en 2009

Association between diabetes mellitus and angina after acute myocardial infarction: analysis of the TRIUMPH prospective cohort study

artículo científico publicado en 2014

Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events

artículo científico publicado en 2005

Association between hyperglycemia at admission during hospitalization for acute myocardial infarction and subsequent diabetes: insights from the veterans administration cardiac care follow-up clinical study

artículo científico publicado en 2013

Association between renal function and circulating levels of natriuretic peptides (from the Dallas Heart Study).

artículo científico publicado en 2008

Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation

Association of Growth Differentiation Factor-15 with Coronary Atherosclerosis and Mortality in a Young, Multiethnic Population: Observations from the Dallas Heart Study ⬇️

artículo científico publicado el 7 de noviembre de 2011

Association of Intensive Lifestyle Intervention, Fitness and Body Mass Index with Risk of Heart Failure in Overweight or Obese Adults with Type 2 Diabetes Mellitus: An Analysis from the Look AHEAD Trial

artículo científico publicado en 2020

Association of Lipoprotein-Associated Phospholipase A2 Mass and Activity with Coronary and Aortic Atherosclerosis: Findings from the Dallas Heart Study

artículo científico publicado en 2008

Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial

artículo científico publicado en 2020

Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis

artículo científico publicado en 2020

Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population ⬇️

artículo científico publicado el 8 de diciembre de 2010

Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes

artículo científico publicado en 2004

Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS

scientific article published on 20 October 2019

Association of prediabetes by fasting glucose and/or haemoglobin A1c levels with subclinical atherosclerosis and impaired renal function: observations from the Dallas Heart Study

artículo científico publicado en 2014

Association of race with complications and prognosis following acute coronary syndromes

artículo científico publicado en 2004

Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study

artículo científico publicado en 2006

Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study

artículo científico publicado en 2005

Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease

scientific article published on 20 October 2019

Associations of four circulating chemokines with multiple atherosclerosis phenotypes in a large population-based sample: results from the dallas heart study

artículo científico publicado en 2010

Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults ⬇️

artículo científico publicado el 19 de mayo de 2013

Atrial Fibrillation, Type 2 Diabetes, and Non-Vitamin K Antagonist Oral Anticoagulants: A Review.

artículo científico publicado en 2017

B-type natriuretic peptide in cardiovascular disease

artículo científico publicado en 2003

Biomarkers in clinical trials: can we move from fortune telling to disease profiling?

artículo científico publicado en 2011

Biomarkers of Chronic Cardiac Injury and Hemodynamic Stress Identify a Malignant Phenotype of Left Ventricular Hypertrophy in the General Population ⬇️

artículo científico publicado el 5 de diciembre de 2012

Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy

artículo científico publicado en 2016

Body Size Misperception: A Novel Determinant in the Obesity Epidemic ⬇️

artículo científico publicado el 11 de octubre de 2010

Body fat distribution and incident cardiovascular disease in obese adults

artículo científico publicado en 2015

Cardiomyopathy in type 2 diabetes: update on pathophysiological mechanisms

artículo científico publicado en 2008

Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose Lowering Agents -Post-hoc Analyses from DECLARE-TIMI 58

artículo científico publicado en 2020

Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists: a Review for the General Cardiologist

artículo científico publicado en 2020

Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.

artículo científico publicado en 2017

Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c.

artículo científico publicado en 2015

Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes

scientific article published on 23 September 2020

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

scientific article published on 26 August 2018

Cardiovascular adverse events in the drug-development program of bupropion for smoking cessation: A systematic retrospective adjudication effort

artículo científico publicado en 2017

Cardiovascular and renal benefits of dapagliflozin in patients with short and long-standing type 2 diabetes: Analysis from the DECLARE-TIMI 58 trial

artículo científico publicado en 2020

Cardiovascular disease and type 2 diabetes mellitus: regulating glucose and regulating drugs

artículo científico publicado en 2009

Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: a subgroup analysis of the randomized CAROLINA trial

artículo científico publicado en 2020

Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7)

scientific article published on 15 April 2019

Circulating levels of matrix metalloproteinase-9 and abdominal aortic pathology: From the Dallas Heart Study ⬇️

artículo científico publicado el 1 de octubre de 2011

Circulating lymphotoxin β receptor and atherosclerosis: observations from the Dallas Heart Study

artículo científico publicado en 2010

Clinical characteristics, vascular function, and inflammation in women with angina in the absence of coronary atherosclerosis: the Dallas Heart Study

artículo científico publicado en 2011

Combating childhood type 2 diabetes mellitus: it will take a village

scientific article published on 01 December 2007

Comparison of Adipose Distribution Indices with Gold Standard Body Composition Assessments in the EMPA-REG H2H SU Trial: A Body Composition Sub-Study

artículo científico publicado en 2015

Comparison of coronary artery calcium detected by electron beam tomography in patients with to those without symptomatic coronary heart disease

artículo científico publicado en 2003

Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial).

artículo científico publicado en 2002

Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus

scientific article published on 01 April 2019

Composite Primary End Points in Cardiovascular Outcomes Trials Involving Type 2 Diabetes Patients: Should Unstable Angina Be Included in the Primary End Point?

artículo científico publicado en 2017

Contemporary Trends in Prescription of Dipeptidyl Peptidase-4 Inhibitors in the Context of US Food and Drug Administration Warnings of Heart Failure Risk

artículo científico publicado en 2020

Contemporary patterns of discharge aspirin dosing after acute myocardial infarction in the United States: results from the National Cardiovascular Data Registry (NCDR).

artículo científico publicado en 2014

Coronary Artery Calcium Improves Risk Classification in Younger Populations

artículo científico publicado en 2015

Coronary artery calcium score, risk factors, and incident coronary heart disease events

artículo científico publicado en 2006

Coronary revascularization strategies in patients with diabetes and multivessel coronary artery disease: has the final chapter been written?

artículo científico publicado en 2014

Correction to: Comparison of Adipose Distribution Indices with Gold Standard Body Composition Assessments in the EMPA-REG H2H SU Trial: A Body Composition Sub-Study.

artículo científico publicado en 2018

Corrections needed to 2016 ESC guideline and AHA scientific statement on heart failure

artículo científico publicado en 2017

DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality

artículo científico publicado en 2017

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial

artículo científico publicado en 2019

Dapagliflozin and Cardiac, Kidney and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58

scientific article published on 03 August 2020

Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction

scientific article published on 18 March 2019

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

scientific article published on 10 November 2018

Declare-Timi 58: Participants' Baseline Characteristics

artículo científico publicado en 2018

Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)

artículo científico publicado en 2018

Design and rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61 (CAMELLIA-TIMI 61) trial

artículo científico publicado en 2018

Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) - DEVOTE 1.

artículo científico publicado en 2016

Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease

scientific article published in 2022

Diabetes and cardiovascular disease: current opinions and future directions

artículo científico publicado en 1999

Diabetes and heart failure in patients with coronary disease: separating markers from mediators

artículo científico publicado en 2010

Diabetes and ischemic heart disease

artículo científico publicado en 1999

Diabetes medications and cardiovascular outcome trials: Lessons learned

artículo científico publicado en 2017

Diabetes mellitus and cardiovascular disease. Pandora's box has been opened

artículo científico publicado en 2004

Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarction

artículo científico publicado en 2012

Diabetes mellitus in patients with myocardial infarction complicated by heart failure: a ‘low ejection fraction’ equivalent? ⬇️

artículo científico publicado el 1 de noviembre de 2010

Diabetes-related knowledge, atherosclerotic risk factor control, and outcomes in acute coronary syndromes

artículo científico publicado en 2005

Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of the inTandem 1 and 2 Studies

scientific article published on 14 September 2020

Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists

artículo científico publicado en 2008

Differential associations between soluble cellular adhesion molecules and atherosclerosis in the Dallas Heart Study: a distinct role for soluble endothelial cell-selective adhesion molecule

artículo científico publicado en 2009

Discordant effects of rosiglitazone on novel inflammatory biomarkers ⬇️

artículo científico publicado el 16 de febrero de 2013

Disparities in counseling for lifestyle modification among obese adults: insights from the Dallas Heart Study

artículo científico publicado en 2011

Don't miss this opportunity: Diagnosing diabetes

artículo científico publicado en 2003

Dose-dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial

scientific article published on 01 August 2019

Drugs for type 2 diabetes mellitus: the imperative for cardiovascular outcome assessment

artículo científico publicado en 2012

Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization

artículo científico publicado en 2017

Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults ⬇️

artículo científico publicado el 19 de septiembre de 2012

EFFECT OF EXTENDED-RELEASE NIACIN ON REACTIVE HYPEREMIA PERIPHERAL ARTERIAL TONOMETRY AND ENDOTHELIAL PROGENITOR CELL MOBILIZATION: INSIGHTS FROM THE ATHEROSCLEROSIS LESION PROGRESSION INTERVENTION USING NIACIN EXTENDED RELEASE IN SAPHENOUS VEIN GRA

artículo científico publicado en 2015

Early statin initiation and outcomes in patients with acute coronary syndromes

artículo científico publicado en 2002

Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial

scientific article published on 27 January 2020

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus

scientific article published on 18 March 2019

Effect of Extended-Release Niacin on Carotid Intima Media Thickness, Reactive Hyperemia, and Endothelial Progenitor Cell Mobilization: Insights From the Atherosclerosis Lesion Progression Intervention Using Niacin Extended Release in Saphenous Vein G

Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis: Insights from the Atherosclerosis Lesion Progression Intervention Using Niacin Extended Release in Saphenous Vein Grafts (ALPINE-SVG) Pilot Trial

scientific article published on 01 October 2015

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial

artículo científico publicado en 2020

Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial

artículo científico publicado en 2019

Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial

scientific article published on 01 January 2019

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

artículo científico publicado en 2015

Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS.

artículo científico publicado en 2016

Effect of glucose-insulin-potassium (GIK) infusion on biomarkers of cardiovascular risk in ST elevation myocardial infarction (STEMI): insight into the failure of GIK.

artículo científico publicado en 2007

Effect of glucose-insulin-potassium infusion on plasma free fatty acid concentrations in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction

artículo científico publicado en 2004

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

artículo científico publicado en 2018

Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials

scientific article published on 24 October 2020

Effect of treatment with rosiglitazone on high-sensitivity cardiac troponin levels among patients with type 2 diabetes mellitus

artículo científico publicado en 2015

Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c

artículo científico publicado en 2014

Effects of Epeleuton, a Novel Synthetic Second-Generation n-3 Fatty Acid, on Non-Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers

artículo científico publicado en 2020

Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial

artículo científico publicado en 2020

Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial

artículo científico publicado en 2020

Effects of Sodium-Glucose Cotransporter 1 and 2 Inhibitors on Cardiovascular and Kidney Outcomes in Type 2 Diabetes: A Meta-analysis Update

artículo científico publicado en 2020

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes

artículo científico publicado en 2017

Effects of Sotagliflozin Combined with Intensive Insulin Therapy in Young Adults with Poorly Controlled Type 1 Diabetes: The JDRF Sotagliflozin Study

scientific article published on 08 July 2020

Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease

artículo científico publicado en 2009

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial

artículo científico publicado en 2019

Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial

artículo científico publicado en 2020

Effects of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials

artículo científico publicado en 2020

Effects of ranolazine on quality of life among patients with diabetes mellitus and stable angina

artículo científico publicado en 2014

Effects of sodium glucose co-transporter 2 inhibitors on the kidney

artículo científico publicado en 2018

Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 Study

scientific article published on 16 December 2019

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes

artículo científico

Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients with Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV Trial

artículo científico publicado en 2020

Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel

artículo científico

Electrocardiographic patterns of proximal left anterior descending artery occlusion in ST-elevation myocardial infarction may be modified by 3-vessel coronary artery disease

artículo científico publicado en 2012

Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes

artículo científico publicado en 2005

Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial

artículo científico publicado en 2019

Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus

artículo científico publicado en 2016

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

artículo científico publicado en 2017

Evaluating the Quality of Comprehensive Cardiometabolic Care for Patients With Type 2 Diabetes in the U.S.: The Diabetes Collaborative Registry

artículo científico publicado en 2016

Evaluation of coronary artery calcium screening strategies focused on risk categories: the Dallas Heart Study

artículo científico publicado en 2009

Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).

artículo científico publicado en 2013

Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial

artículo científico publicado en 2009

Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association

artículo científico publicado en 2016

Executive Summary: Heart Disease and Stroke Statistics—2014 Update

article

Executive Summary: Heart Disease and Stroke Statistics—2015 Update

article

Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association

artículo científico

FDA guidance on antihyperglyacemic therapies for type 2 diabetes: One decade later

scientific article published on 12 March 2019

Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial

scientific article published on 01 December 2018

Glomerular Filtration Rate and Associated Risks of Cardiovascular Events, Mortality, and Severe Hypoglycemia in Patients with Type 2 Diabetes: Secondary Analysis (DEVOTE 11)

artículo científico publicado en 2019

Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure: The Need for Further Evidence Generation and Practice Guidelines Optimization

scientific article published on 21 September 2020

Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Trial

artículo científico publicado en 2015

Glucose-lowering targets for patients with cardiovascular disease: focus on inpatient management of patients with acute coronary syndromes

artículo científico publicado en 2010

Glycaemic control and cardiovascular risk factor management in patients with diabetes with and without coronary artery disease: insights from the diabetes mellitus status in Canada survey

scientific article published on 01 October 2016

Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank

artículo científico publicado en 2019

Glycated hemoglobin in 14,850 adolescent blood donors: a pilot screening program

artículo científico publicado en 2014

Gradient of Risk and Associations with Cardiovascular Efficacy of Ertugliflozin by Measures of Kidney Function: Observations from VERTIS CV

artículo científico publicado en 2020

HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study

artículo científico publicado en 2018

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

artículo científico publicado en 2012

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

artículo científico publicado en 2014

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association

artículo científico publicado en 2015

Heart Failure Considerations of Antihyperglycemic Medications for Type 2 Diabetes

artículo científico publicado en 2016

Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues

scientific article published on 16 December 2019

Heart Failure Epidemiology in Patients With Diabetes Mellitus Without Coronary Heart Disease

scientific article published on 10 November 2018

Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus

artículo científico publicado en 2019

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial

artículo científico publicado en 2015

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

artículo científico publicado en 2014

Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial

artículo científico

High prevalence of elevated haemoglobin A1C among adolescent blood donors: Results from a voluntary screening programme including 31,546 adolescents

artículo científico publicado en 2015

Higher Natriuretic Peptide Levels Associate With a Favorable Adipose Tissue Distribution Profile ⬇️

artículo científico publicado el 16 de abril de 2013

Highlights from the American College of Cardiology 49th Annual Scientific Sessions: March 12 to 15, 2000.

artículo científico publicado en 2000

Highlights from the XXII congress of the European Society of Cardiology: August 26 to 30, 2000

scientific article published on 01 January 2001

Homoarginine and cardiovascular outcome in the population-based Dallas Heart Study

artículo científico publicado en 2014

Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin

artículo científico publicado en 2017

INTERACTIONS BETWEEN SMOKING, CIRCULATING PULMONARY SURFACTANT PROTEIN-B AND AORTIC ATHEROSCLEROSIS IN THE DALLAS HEART STUDY

artículo científico publicado en 2011

Identifying Familial Hypercholesterolemia Using a Blood Donor Screening Program With More Than 1 Million Volunteer Donors

scientific article published on 01 July 2019

Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions

artículo científico publicado en 2020

Impact of empagliflozin in patients with diabetes and heart failure

artículo científico publicado en 2016

Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management

artículo científico publicado en 2005

Implications of family history of myocardial infarction in young women

scientific article published on 01 September 2007

Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program

scientific article published on 04 March 2019

Inaccuracy of estimated resting oxygen uptake in the clinical setting

artículo científico publicado en 2013

Increased cardiovascular risk associated with diabetes in Dallas County

artículo científico publicado en 2006

Independent associations between metabolic syndrome, diabetes mellitus and atherosclerosis: observations from the Dallas Heart Study

artículo científico publicado en 2008

Infarct-related coronary artery patency and medication use prior to ST-segment elevation myocardial infarction

artículo científico publicado en 2006

Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators

artículo científico publicado en 2000

Influence of diabetes on long-term outcome among unselected patients with acute coronary events

artículo científico publicado en 2004

Influence of race and sex on lipoprotein-associated phospholipase A2 levels: observations from the Dallas Heart Study.

artículo científico publicado en 2007

Influence of the Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: results from the National Cardiovascular Network Database

artículo científico publicado en 2003

Insulin resistance and risk for incident heart failure

artículo científico publicado en 2013

Insulin resistance is associated with significant clinical atherosclerosis in nondiabetic patients with acute myocardial infarction

artículo científico publicado en 2013

Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetes

artículo científico publicado en 2017

Interactions between smoking, pulmonary surfactant protein B, and atherosclerosis in the general population: the Dallas Heart Study

artículo científico publicado en 2011

Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study.

artículo científico publicado en 2007

International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS

scientific article published on 28 August 2019

Interview with Dr. Scott Grundy during AHA EPI/NPAM Meeting in March 2011 ⬇️

artículo científico publicado el 22 de junio de 2011

Is cardiorespiratory fitness a determinant of cardiomyopathy in the setting of type 2 diabetes?

artículo científico publicado en 2014

Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA

artículo científico publicado en 2019

Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease

scientific article published on 01 November 2018

Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY mana

artículo científico publicado en 2015

Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial

artículo científico publicado en 2019

Low hemoglobin A1c and risk of all-cause mortality among US adults without diabetes.

artículo científico publicado en 2010

Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)

artículo científico publicado en 2019

Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score

artículo científico publicado en 2019

Major Bleeding in Patients With Diabetes and Atrial Fibrillation Treated With New Oral Anticoagulants-Reply

artículo científico publicado en 2017

Management of patients with diabetes and heart failure with reduced ejection fraction: An international comparison

scientific article published on 25 September 2018

Medicaid Expansion and Utilization of Antihyperglycemic Therapies

scientific article published on 04 September 2020

Metabolic Effects of Exercise Training Among Fitness-Nonresponsive Patients With Type 2 Diabetes: The HART-D Study

artículo científico publicado en 2015

Metabolic syndrome is not associated with increased mortality or cardiovascular risk in nondiabetic patients with a new diagnosis of coronary artery disease

artículo científico publicado en 2010

Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial

artículo científico publicado en 2019

Metformin in heart failure

artículo científico publicado en 2007

Metformin in patients with type 2 diabetes and kidney disease: a systematic review

artículo científico publicado en 2014

Metformin therapy in patients with type 2 diabetes complicated by heart failure

artículo científico publicado en 2007

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes

artículo científico publicado en 2017

Multimodality Strategy for Cardiovascular Risk Assessment: Performance in 2 Population-Based Cohorts

artículo científico publicado en 2017

Nesiritide in acute heart failure

scientific article published on 01 September 2003

New drugs for the treatment of diabetes mellitus: part I: Thiazolidinediones and their evolving cardiovascular implications

artículo científico publicado en 2008

New drugs for the treatment of diabetes: part II: Incretin-based therapy and beyond

scientific article published on January 2008

No association between hemoglobin A1c and in-hospital mortality in patients with diabetes and acute myocardial infarction ⬇️

artículo científico publicado el 1 de abril de 2011

Pathways to Cardiorenal Complications in Type 2 Diabetes Mellitus: A Need to Rethink

artículo científico publicado en 2018

Patients with diabetes mellitus and atrial fibrillation treated with NOACs: Meta-analysis of 8 outcomes in 58, 634 patients across 4 randomized controlled trials

artículo científico publicado en 2020

Patterns and predictors of intensive statin therapy among patients with diabetes mellitus after acute myocardial infarction

artículo científico publicado en 2014

Patterns of glucose-lowering medication use in patients with type 2 diabetes and heart failure. Insights from the Diabetes Collaborative Registry (DCR)

scientific article published on 18 June 2018

Physical activity participation, health perceptions, and cardiovascular disease mortality in a multiethnic population: The Dallas Heart Study ⬇️

artículo científico publicado el 1 de junio de 2012

Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment

artículo científico publicado en 2009

Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization ⬇️

artículo científico publicado el 25 de agosto de 2012

Predicting Adverse Outcomes After Myocardial Infarction Among Patients With Diabetes Mellitus

scientific article published on 24 May 2016

Predicting cardiovascular risk in type 2 diabetes: the heterogeneity challenges

artículo científico

Predictors of coronary artery disease in patients with left bundle branch block undergoing coronary angiography

artículo científico publicado en 2006

Prevalence and determinants of troponin T elevation in the general population

scientific article published on 17 April 2006

Prevalence of glucose abnormalities among patients presenting with an acute myocardial infarction

artículo científico publicado en 2014

Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 Diabetes

artículo científico publicado en 2018

Prevention of CV outcomes in antihyperglycaemic drug-naïve patients with type 2 diabetes with, or at elevated risk of, ASCVD: to start or not to start with metformin

scientific article published on 17 November 2020

Purulent pericarditis: report of 2 cases and review of the literature

artículo científico publicado en 2009

Quality of Care of the Initial Patient Cohort of the Diabetes Collaborative Registry®.

artículo científico publicado en 2017

Race and gender differences in C-reactive protein levels

artículo científico publicado en 2005

Race-specific associations of myeloperoxidase with atherosclerosis in a population-based sample: The Dallas Heart Study ⬇️

artículo científico publicado el 22 de agosto de 2011

Racial disparity in clinical outcomes following primary percutaneous coronary intervention for ST elevation myocardial infarction: influence of process of care

artículo científico publicado en 2007

Randomized comparison of the effects of rosiglitazone vs. placebo on peak integrated cardiovascular performance, cardiac structure, and function

artículo científico publicado en 2010

Range of Risk Factor Levels: Control, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes Mellitus

artículo científico publicado en 2017

Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high

artículo científico publicado en 2018

Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: An NCDR® Research to Practice project

artículo científico publicado en 2017

Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications.

artículo científico publicado en 2009

Recognition of incident diabetes mellitus during an acute myocardial infarction

artículo científico publicado en 2015

Recognized Outstanding Reviewers for Circulation in 2017.

artículo científico publicado en 2017

Recognized Outstanding Reviewers for Circulation in 2019

scientific article published on 16 December 2019

Recognized Outstanding Reviewers for Circulation in 2020

artículo científico publicado en 2020

Relation of black race between high density lipoprotein cholesterol content, high density lipoprotein particles and coronary events (from the Dallas Heart Study).

artículo científico publicado en 2015

Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study).

artículo científico publicado en 2005

Relation of family history of myocardial infarction and the presence of coronary arterial calcium in various age and risk factor groups

artículo científico publicado en 2007

Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study).

artículo científico publicado en 2006

Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study

scientific article published on 29 August 2018

Relation of regional fat distribution to left ventricular structure and function

artículo científico publicado en 2013

Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study.

artículo científico publicado en 2005

Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without SGLT2 inhibitor therapy in DECLARE-TIMI 58

scientific article published on 02 December 2020

Relationship between glycosylated hemoglobin assessment and glucose therapy intensification in patients with diabetes hospitalized for acute myocardial infarction

artículo científico publicado en 2012

Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus

scientific article published on 01 April 2019

Reply: In regard to the TERISA trial

artículo científico publicado en 2014

Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus

artículo científico publicado en 2017

Resolving drug effects from class effects among drugs for type 2 diabetes mellitus: more support for cardiovascular outcome assessments ⬇️

artículo científico publicado el 6 de abril de 2011

Response by Bergmark et al to Letter Regarding Article, "Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial"

scientific article published on 27 January 2020

Response to Comment on Segar et al. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care 2019;42:2298-2306

scientific article published on 01 February 2020

Response to Letter Regarding Article, "Heart Failure, Saxagliptin and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial".

artículo científico publicado en 2015

Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Interven

artículo científico publicado en 2016

Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes

scientific article published on 01 August 2018

Risk factors for kidney disorders in patients with type 2 diabetes at high cardiovascular risk: An exploratory analysis (DEVOTE 12)

artículo científico publicado en 2020

SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation

artículo científico publicado en 2020

SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation

artículo científico publicado en 2020

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

artículo científico publicado en 2018

SUN-LB015 Baseline Characteristics and Effects on CV and Kidney Outcomes with Linagliptin Versus Placebo, Across GFR Categories in CARMELINA.

artículo científico publicado en 2019

Safety of dapagliflozin in a broad population of patients with type 2 diabetes - analyses from the DECLARE - TIMI 58 study

scientific article published on 02 April 2020

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial

artículo científico publicado en 2014

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

artículo científico publicado en 2013

Science in a Time of Crisis

artículo científico publicado en 2020

Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study

artículo científico publicado en 2009

Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).

artículo científico publicado en 2017

Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS

artículo científico publicado en 2018

Sex differences in the association between leptin and CRP: results from the Dallas Heart Study

artículo científico publicado en 2006

Sex differences in the relationship between C-reactive protein and body fat. ⬇️

artículo científico publicado en 2009

Sex-Based Differences in Cardiometabolic Biomarkers

artículo científico publicado en 2017

Should Metformin Remain First-Line Medical Therapy for Patients with Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease? An Alternative Approach

scientific article published on 14 July 2018

Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS

scientific article published on 03 September 2019

Sodium-glucose co-transporter inhibition in the treatment of diabetes: sweetening the pot

artículo científico publicado en 2015

Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitus

artículo científico publicado en 2016

Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study

artículo científico publicado en 2018

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

artículo científico publicado en 2020

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

artículo científico publicado en 2020

State-of-the-Art: Hypo-responsiveness to oral antiplatelet therapy in patients with type 2 diabetes mellitus.

artículo científico publicado en 2015

Subclinical diabetes mellitus: is it really "sub-clinical"?

artículo científico publicado en 2003

Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study

artículo científico publicado en 2013

Systems-based improvement in door-to-balloon times at a large urban teaching hospital: a follow-up study from Parkland Health and Hospital System

artículo científico publicado en 2009

Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study

artículo científico publicado en 2015

Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute dynamic registry

artículo científico publicado en 2011

Temporal trends and hospital variation in the management of severe hyperglycemia among patients with acute myocardial infarction in the United States

artículo científico publicado en 2013

The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context

artículo científico publicado en 2009

The Dallas Bed Rest and Training Study: Revisited After 50 Years

artículo científico publicado en 2019

The Editor's roundtable: diabetes mellitus and coronary heart disease

scientific article published on 24 July 2006

The association between HDL particle concentration and incident metabolic syndrome in the multi-ethnic Dallas Heart Study

artículo científico publicado en 2016

The association between peptidoglycan recognition protein-1 and coronary and peripheral atherosclerosis: Observations from the Dallas Heart Study

artículo científico publicado en 2008

The association of differing measures of overweight and obesity with prevalent atherosclerosis: the Dallas Heart Study

artículo científico publicado en 2007

The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial

artículo científico publicado en 2018

The effect of a disease management algorithm and dedicated postacute coronary syndrome clinic on achievement of guideline compliance: results from the parkland acute coronary event treatment study

artículo científico publicado en 2008

The effect of intensive glucose control on all-cause and cardiovascular mortality, myocardial infarction and stroke in persons with type 2 diabetes mellitus: a systematic review and meta-analysis

scientific article published on 04 December 2009

The effect of rosiglitazone on integrated cardiovascular performance, cardiac structure, function and myocardial triglyceride: trial design and rationale

artículo científico publicado en 2009

The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: A randomised, placebo-controlled trial ⬇️

artículo científico publicado el 8 de noviembre de 2011

The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone increases bone resorption in women with type 2 diabetes: a randomized, controlled trial

artículo científico publicado en 2010

The relationship between C-reactive protein and atherosclerosis differs on the basis of body mass index: the Dallas Heart Study

artículo científico publicado en 2012

The relationship of body mass and fat distribution with incident hypertension: observations from the Dallas Heart Study

artículo científico publicado en 2014

The reliability and prognosis of in-hospital diagnosis of metabolic syndrome in the setting of acute myocardial infarction

artículo científico publicado en 2013

The reliability of in-hospital diagnoses of diabetes mellitus in the setting of an acute myocardial infarction

artículo científico publicado en 2014

Thiazolidinediones and risk for atherosclerosis: pleiotropic effects of PPar gamma agonism

artículo científico publicado en 2006

Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence?

artículo científico publicado en 2005

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

scientific article published on 01 September 2019

Treatment delay in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a key process analysis of patient and program factors

artículo científico publicado en 2007

Trends in Aggregate Use and Associated Expenditures of Antihyperglycemic Therapies Among US Medicare Beneficiaries Between 2012 and 2017

scientific article published on 30 September 2019

Trends in Hospitalizations for Heart Failure and Ischemic Heart Disease Among US Adults With Diabetes

scientific article published on 25 November 2020

Two Tales: One Story. EMPEROR-Reduced and DAPA-HF

scientific article published on 24 September 2020

Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association

artículo científico publicado en 2014

Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association

artículo científico publicado en 2014

Type of β-blocker use among patients with versus without diabetes after myocardial infarction

artículo científico publicado en 2014

U.S. PATTERNS OF DRUG UTILIZATION AND PRESCRIPTION FILLS FOR PROVEN CARDIOPROTECTIVE ANTI-HYPERGLYCEMIC AGENTS

scientific article published in 2022

Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromes

artículo científico publicado en 2006

Urinary tract infection in patients with acute coronary syndrome: a potential systemic inflammatory connection

artículo científico publicado en 2005

Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease: A Review

artículo científico publicado en 2020

Use of aldosterone antagonists at discharge after myocardial infarction: results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get with the Guidelines (GWTG).

artículo científico publicado en 2013

Variability of clopidogrel response in patients with type 2 diabetes mellitus

artículo científico

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda